Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis
- Sponsor
- Cappagh National Orthopaedic Hospital
- Study ID
- NCT07489521
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Intraarticular Injection
- Osteo Arthritis Knee
- Osteoarthritis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- Arthrosamid® 2.5% iPAAG injectable implant — DEVICEArthrosamid is a non-biodegradable, 2.5% polyacrylamide hydrogel (iPAAG) injection designed as a long-lasting, non-surgical treatment for knee osteoarthritis. It acts as a synovial implant that provides cushioning, reduces pain, and improves mobility for up to 3-4 years, often delaying the need for knee replacement surgery.
- Steroid Drug — DRUGdexamethasone 8mg, methylprednisolone 80mg and bupivacaine 5ml 0.25%, intra articular injection
Study Details
This study will be a randomised control trial of the use of intra-articular Arthrosamid® a novel intraarticular hydrogel vs. standard of care (steroid and local anaesthetic) for the non-operative management of knee osteoarthritis.
Key Dates
- First listed
- Mar 24, 2026
- Start date
- Jan 29, 2026
- Status verified
- Mar 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ArthrosamidPatient with knee osteoarthritis Arthrosamid Injection. This is a non-biodegradable 2.5% iPAAG injectable implant. It is given once.
- Active Comparator: SteroidPatient with knee osteoarthritis Steroid arm is as follow with one injection containing: Dexamethasone 8mg and methylprednisolone 80mg and bupivacaine 0.25% 5 mls.
Primary Outcome Measure
Western Ontario and McMaster Universities Arthritis Index (WOMAC). [ Time Frame: Before the onset of treatment, then 3, 6, 12 months after with possibility of follow up 18 months. ]
Central Contacts
- SEAN TEE LIM, M.D(01) 814 0400
- Shane Crilly, MD(01) 814 0400
Find similar trials
Related Studies
- Clinical Orthopaedic Data Bank (Acute and Chronic)Recruiting · University of Florida · Gainesville, Florida
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the ShoulderPHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the KneePHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the HipPHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania